Company: IXHL
Filing Date: 2025-12-18
Form Type: 8-K
Source: 0001213900-25-123041
Chunk: 0

Company: Incannex Healthcare Inc.
Filing Date: 2025-12-18
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

On December 18, 2025, Incannex Healthcare Inc. (“we” or the “ Company”) announced at the 2025 annual meeting of
stockholders (the “ Annual Meeting”) that there were not present or represented by proxy a sufficient number of shares of our
common stock to constitute a quorum, primarily due to Proposal No. 2, relating to the ratification of the appointment of its independent
registered accounting firm (the “ Auditor Ratification Proposal”), being classified as a non-routine proposal because of an
administrative error by the Company’s transfer agent. Accordingly, we adjourned our Annual Meeting to allow for the solicitation
of additional proxies with respect to the proposals set forth in the Proxy Statement. The Annual Meeting has been adjourned to Thursday,
January 15, 2026, at 11:00 a. m., Gulf Standard Time, and will reconvene only virtually via live audio webcast on the Internet by visiting
www. meetnow. global/MD59M9U.

We have engaged with the transfer agent and other relevant parties to seek reclassification of the Auditor Ratification Proposal and expect
that the Auditor Ratification Proposal will be reclassified as routine prior to the reconvened Annual Meeting, which would permit brokers,
banks, and other nominees to exercise discretionary voting authority for shares held in “street name.”

During the period of the adjournment, the Company
will continue to solicit proxies with respect to the proposals set forth in the Proxy Statement. Proxies previously submitted in respect
of the Annual Meeting will be voted at the reconvened meeting unless properly revoked, and stockholders who have already submitted a
proxy to vote their shares need not take any action.

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                               Incannex Healthcare Inc.                                             
  Date: December 18, 2025                                    /s/ Joel Latham                        
                               Name:                         Joel Latham                            
                               Title:                        Chief Executive Officer and President